We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
(+14%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$278M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$23.1M |
| 3 |
Morgan Stanley
MS
|
+$22.8M |
| 4 |
AIRC
Apartment Income REIT Corp.
AIRC
|
+$18.5M |
| 5 |
Peloton Interactive
PTON
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$108M |
| 2 |
Microsoft
MSFT
|
+$73.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Financials | 13.46% |
| 3 | Healthcare | 13.26% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
2826
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $202K | ﹤0.01% |
28,897
+3,635
| +14% | +$28.3K |
|
|
PFHD
2827
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $202K | ﹤0.01% |
+13,096
| New | +$191K |
|
2828
Chemung Financial Corp
CHMG
$392M
| $201K | ﹤0.01% |
+5,922
| New | +$204K |
|
|
AGRX
2829
DELISTED
Agile Therapeutics
AGRX
| $200K | ﹤0.01% |
35
+3
| +9% | +$17.7K |
|
2830
Dianthus Therapeutics
DNTH
$6.09B
| $199K | ﹤0.01% |
1,585
+335
| +27% | +$38K |
|
|
BFIN
2831
DELISTED
BankFinancial
BFIN
| $198K | ﹤0.01% |
22,518
+2,789
| +14% | +$22.5K |
|
2832
Stereotaxis
STXS
$141M
| $197K | ﹤0.01% |
38,619
+5,450
| +16% | +$22.3K |
|
2833
CorMedix
CRMD
$584M
| $196K | ﹤0.01% |
26,421
+6,081
| +30% | +$41.3K |
|
|
MRLN
2834
DELISTED
Marlin Business Services Corp
MRLN
| $196K | ﹤0.01% |
16,047
+1,747
| +12% | +$17K |
|
2835
Richmond Mutual Bancorp
RMBI
$254M
| $195K | ﹤0.01% |
14,297
+2,548
| +22% | +$31.2K |
|
|
ENZ
2836
DELISTED
Enzo Biochem, Inc.
ENZ
| $195K | ﹤0.01% |
77,575
+9,309
| +14% | +$20.3K |
|
2837
Lexicon Pharmaceuticals
LXRX
$1.1B
| $194K | ﹤0.01% |
56,689
+6,530
| +13% | +$12.5K |
|
2838
Cabaletta Bio
CABA
$455M
| $193K | ﹤0.01% |
15,454
+2,709
| +21% | +$35.1K |
|
2839
Genco Shipping & Trading
GNK
$1.1B
| $193K | ﹤0.01% |
26,205
+3,600
| +16% | +$26.2K |
|
2840
Hamilton Beach Brands
HBB
$422M
| $193K | ﹤0.01% |
+11,027
| New | +$217K |
|
2841
Comscore
SCOR
$109M
| $193K | ﹤0.01% |
3,872
+637
| +20% | +$28.3K |
|
|
PBIP
2842
DELISTED
Prudential Bancorp, Inc.
PBIP
| $193K | ﹤0.01% |
13,948
+1,666
| +14% | +$20.9K |
|
2843
Information Services Group
III
$251M
| $191K | ﹤0.01% |
58,256
+7,567
| +15% | +$19.8K |
|
2844
Riverview Bancorp
RVSB
$108M
| $191K | ﹤0.01% |
36,250
+4,456
| +14% | +$23K |
|
2845
Harvard Bioscience
HBIO
$29.2M
| $190K | ﹤0.01% |
4,433
+806
| +22% | +$30.1K |
|
2846
Nomura Holdings
NMR
$29.1B
| $189K | ﹤0.01% |
35,435
+2,520
| +8% | +$12.5K |
|
|
ESTE
2847
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $188K | ﹤0.01% |
35,190
+4,964
| +16% | +$17.2K |
|
2848
Gyre Therapeutics
GYRE
$744M
| $187K | ﹤0.01% |
3,958
+692
| +21% | +$30K |
|
|
IVAC
2849
DELISTED
Intevac Inc
IVAC
| $186K | ﹤0.01% |
25,856
+4,196
| +19% | +$25.2K |
|
2850
Kodak
KODK
$983M
| $185K | ﹤0.01% |
22,785
+3,198
| +16% | +$26.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
- RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
- RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
- RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
- RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
- RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.